Ashish Pershad, MD
Interventional Cardiology · Chandler, AZNPI 1194710657
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.6%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Medtronic at 34.0% of the total. Reporting peaked in 2021 at $38,600 and has fallen 82.8% since, to $6,655 in 2025. Among interventional cardiology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 417 payments — averaging $269.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$38K
- Edwards Lifesciences$24K
- Philips North America LLC$14K
- Asahi Intecc USA, Inc.$11K
- Abiomed$5K
- Abbott$4K
- plus $16K from 27 others
Across 137 payments — averaging $9359.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Edwards Lifesciences$641K
- Abbott$415K
- Boston Scientific$226K
What the payments were for
- Consulting fees$25,15022%
- Speaking & faculty fees$54,51349%
- Grants$1,0981%
- Travel & lodging$12,94012%
- Food & beverage$18,51516%
- Entertainment$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 71 | $38,167 |
| Edwards Lifesciences | 89 | $23,544 |
| Philips North America LLC | 26 | $14,103 |
| Asahi Intecc USA, Inc. | 11 | $11,376 |
| Abiomed | 32 | $4,651 |
| Abbott | 50 | $4,274 |
| Biotronik Inc. | 11 | $3,917 |
| W. L. Gore & Associates, Inc. | 5 | $3,296 |
| Teleflex LLC | 19 | $2,448 |
| Boston Scientific | 42 | $2,276 |
| Livanova USA, Inc. | 2 | $2,240 |
| Terumo Medical Corporation | 4 | $318 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $249 |
| Cathworks, Inc. | 1 | $170 |
| Shockwave Medical, Inc | 1 | $169 |
| Novartis | 10 | $157 |
| Sanofi-aventis U.S. LLC | 1 | $125 |
| Cardiac Dimensions, Inc. | 1 | $97 |
| Boehringer Ingelheim | 4 | $90 |
| Amgen | 4 | $81 |
| Biosense Webster, Inc. | 1 | $77 |
| EKOS Corporation | 3 | $64 |
| Johnson & Johnson | 4 | $62 |
| Atricure, Inc. | 1 | $60 |
| AstraZeneca | 4 | $57 |
| Mimedx Group, Inc. | 1 | $46 |
| Corindus Inc. | 1 | $39 |
| Astellas Pharma US Inc | 1 | $25 |
| Chiesi USA, Inc. | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Heartflow, Inc. | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$18,970
- COREVALVE EVOLUT R$17,180
- Resolute$15,247
- (9520) IGT Devices Undivided$13,200
- ASAHI PTCA Guide Wire$11,170
- Impella$3,777
- Product in Development$3,200
- RESOLUTE ONYX$3,036
- Pulsar$2,293
- Astron; Pulsar; AstronPulsar$2,293
- Orsiro$2,293
- PK Papyrus$2,293
- TandemLife$2,225
- Passeo$2,000
- Mitra Clip system$1,502
- MANTA$1,061
- EVOQUE$859
- GUIDELINER$617
- FFRangio$501
- GENERAL - THERAPIES$400
How this compares
$112,249 in reported general payments places this provider in the 90th percentile of 223 interventional cardiology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 33 | $306 |
| Atorvastatin Calcium | 13 | $98 |
| Carvedilol | 13 | $77 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Chandler
- Pratik DalalChandler$142K
- Prakash BalanChandler$85K
- Abhishek SawantChandler$81K
- Kush AgrawalChandler$44K
- Georges NseirChandler$21K
- Paul SorajjaPhoenix$1.1M
- Hursh NaikAvondale$781K
- Thomas WaggonerTucson$617K
- Timothy ByrnePhoenix$614K
- Haidar YassinPhoenix$434K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.